<?xml version='1.0' encoding='utf-8'?>
<Document xmlns="urn:iso:std:iso:20022:tech:xsd:pacs.002.001.10"><FIToFIPmtStsRpt><GrpHdr><MsgId>PACS002-ACSC-2949449b</MsgId><CreDtTm>2025-10-01T13:00:00+00:00Z</CreDtTm></GrpHdr><OrgnlGrpInfAndSts><OrgnlMsgId>PAIN-2025-10-01-Swift_Pharma_LLC-ceab7049</OrgnlMsgId><OrgnlMsgNmId>pain.001.001.09</OrgnlMsgNmId><GrpSts>PART</GrpSts></OrgnlGrpInfAndSts><OrgnlPmtInfAndSts><OrgnlPmtInfId>PMTINF-2025-10-01-47bfef</OrgnlPmtInfId><TxInfAndSts><StsId>STS-a8df0a54</StsId><OrgnlInstrId>INST-20251001-00509</OrgnlInstrId><OrgnlEndToEndId>E2E-20251001-00509</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-10-01T13:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="JPY">10067.03</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-ba4f5e55</StsId><OrgnlInstrId>INST-20251001-00521</OrgnlInstrId><OrgnlEndToEndId>E2E-20251001-00521</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-10-01T13:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="CHF">11432.63</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-c9e4228e</StsId><OrgnlInstrId>INST-20251001-00524</OrgnlInstrId><OrgnlEndToEndId>E2E-20251001-00524</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-10-01T13:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="GBP">4289.68</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-a7ba8284</StsId><OrgnlInstrId>INST-20251001-00608</OrgnlInstrId><OrgnlEndToEndId>E2E-20251001-00608</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-10-01T13:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="USD">1526.14</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts></OrgnlPmtInfAndSts></FIToFIPmtStsRpt></Document>